Five-Year Summary

Bayer on track for success

Sales1
(€ billion)
Sales (bar chart)Sales (bar chart)
EBITDA before Special Items1
(€ billion)
EBITDA Before Special Items (bar chart)EBITDA Before Special Items (bar chart)
Earnings per Share1
(€)
EPS (bar chart)EPS (bar chart)
Market Capitalization
(€ billion)
Market Capitalization (bar chart)Market Capitalization (bar chart)
R&D Expenses1
(€ billion)
R&D Expenses (bar chart)R&D Expenses (bar chart)
Recordable Incident Rate
(RIR)
Recordable Incident Rate (RIR) (bar chart)Recordable Incident Rate (RIR) (bar chart)

1 2014 figures restated; figures for 2011 – 2013 as last reported
2 Compound annual growth rate

You can read more about Life Sciences in the Magazine section of this Annual Report.

Five-Year Summary

 

 

2011

 

2012

 

2013

 

2014

 

2015

 

Change from 2014

 

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

 

%

2014 figures restated; figures for 2011 – 2013 as last reported.

1

EBIT = income after income taxes, plus income taxes, plus financial result. This indicator is not defined in the International Financial Reporting Standards.

2

EBIT before special items = EBIT plus special charges, minus special gains. This indicator is not defined in the International Financial Reporting Standards. See also Combined Management Report, Chapter 14.2 “Calculation of EBIT(DA) Before Special Items.”

3

EBITDA = EBIT plus the amortization of intangible assets and the depreciation of property, plant and equipment, plus impairment losses and minus impairment loss reversals, recognized in profit or loss during the reporting period. This indicator is not defined in the International Financial Reporting Standards. See also Combined Management Report, Chapter 14.2 “Calculation of EBIT(DA) Before Special Items.”

4

EBITDA before special items = EBITDA plus special charges, minus special gains. This indicator is not defined in the International Financial Reporting Standards. For details, see Combined Management Report, Chapter 14.2 “Calculation of EBIT(DA) Before Special Items.”

5

The EBITDA margin before special items is calculated by dividing EBITDA before special items by sales. This indicator is not defined in the International Financial Reporting Standards. For details, see Combined Management Report, Chapter 14.2 “Calculation of EBIT(DA) Before Special Items.”

6

Earnings per share as defined in IAS 33 = net income divided by the average number of shares. For details, see Note [16] to the Consolidated Financial Statements.

7

Core earnings per share = earnings per share, plus / minus amortization and impairment losses / impairment loss reversals of intangible assets, impairment losses / impairment loss reversals on property, plant and equipment, plus special charges, minus special gains (other than amortization and impairment losses / impairment loss reversals), plus / minus the related tax effects and the share of the adjustments attributable to noncontrolling interest. This indicator facilitates the comparability of performance over time. It is not defined in the International Financial Reporting Standards. For details, see Combined Management Report, Chapter 14.3 “Core Earnings Per Share.”

8

Gross cash flow = income after income taxes, plus income taxes, plus financial result, minus income taxes paid or accrued, plus depreciation, amortization and impairment losses, minus impairment loss reversals, plus / minus changes in pension provisions, minus gains / plus losses on retirements of noncurrent assets, minus gains from the remeasurement of already held assets in step acquisitions. The change in pension provisions includes the elimination of noncash components of EBIT. It also contains benefit payments during the year. Gross cash flow is not defined in the International Financial Reporting Standards. For details, see Combined Management Report, Chapter 14.5 “Liquidity and Capital Expenditures of the Bayer Group.”

9

Net cash flow = cash flow from operating activities according to IAS 7

10

Full-time equivalents

11

Percentage changes not based on rounded figures

12

LoPC-IR: rate of incidents in which chemicals leak from their primary container, such as pipelines, pumps, tanks or drums, per 200,000 working hours in areas relevant to plant safety

13

1 petajoule = 1015 joules

14

Energy efficiency: quotient of total energy consumption and manufactured sales volume. For Covestro, only manufactured sales volumes that also form the basis for calculating Covestro-specific emissions are taken into account.

15

Portfolio-adjusted in accordance with the Greenhouse Gas Protocol

16

Specific Group emissions are calculated from the total volume of direct emissions and indirect – calculated using the market-based method of the new Scope 2 GHG Protocol – emissions of the subgroups, including the emissions at the Belford Roxo site and emissions from the vehicle fleet, both reported for the Group as a whole, divided by the manufactured sales volume of the three subgroups in metric tons. Quantities attributable to the supply of energy to external companies are deducted from the direct and indirect emissions. At Covestro, neither the by-products sodium hydroxide solution and hydrochloric acid generated during production nor trade products are included in the manufactured sales volume.

17

Volatile organic compounds (VOC) excluding methane

Bayer Group

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

36,528

 

39,741

 

40,157

 

41,339

 

46,324

 

+12.1

EBIT1

 

4,149

 

3,928

 

4,934

 

5,395

 

6,250

 

+15.8

EBIT before special items2

 

5,025

 

5,639

 

5,773

 

5,833

 

7,069

 

+21.2

EBITDA3

 

6,918

 

6,916

 

7,830

 

8,315

 

9,583

 

+15.2

EBITDA before special items4

 

7,613

 

8,280

 

8,401

 

8,685

 

10,266

 

+18.2

EBITDA margin before special items5

 

20.8%

 

20.8%

 

20.9%

 

21.0%

 

22.2%

 

 

Income before income taxes

 

3,363

 

3,176

 

4,207

 

4,414

 

5,245

 

+18.8

Net income

 

2,470

 

2,403

 

3,189

 

3,426

 

4,110

 

+20.0

Earnings per share (€) from continuing and discontinued operations6

 

2.99

 

2.91

 

3.86

 

4.14

 

4.97

 

+20.0

Core earnings per share (€) from continuing operations7

 

4.83

 

5.30

 

5.61

 

5.89

 

6.83

 

+16.0

Gross cash flow8

 

5,172

 

4,556

 

5,832

 

6,707

 

6,999

 

+4.4

Net cash flow from continuing and discontinued operations9

 

5,060

 

4,530

 

5,171

 

5,810

 

6,890

 

+18.6

Net financial debt

 

7,013

 

7,022

 

6,731

 

19,612

 

17,449

 

−11.0

Capital expenditures as per segment table

 

1,666

 

2,012

 

2,155

 

2,484

 

2,556

 

+2.9

Research and development expenses

 

2,932

 

3,013

 

3,406

 

3,537

 

4,281

 

+21.0

Return on equity

 

13.0%

 

13.0%

 

16.2%

 

16.8%

 

17.9%

 

 

Equity ratio

 

36.5%

 

36.1%

 

40.5%

 

28.8%

 

34.4%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bayer AG

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

 

%

Net income

 

1,125

 

889

 

2,498

 

2,454

 

1,361

 

−44.5

Allocation to (withdrawal from) retained earnings

 

(239)

 

(682)

 

761

 

593

 

(706)

 

.

Total dividend payment

 

1,364

 

1,571

 

1,737

 

1,861

 

2,067

 

+11.1

Dividend per share (€)

 

1.65

 

1.90

 

2.10

 

2.25

 

2.50

 

+11.1

 

 

 

 

 

 

 

 

 

 

 

 

 

Employees

 

 

 

 

 

 

 

 

 

 

 

 

Number of employees10 (Dec. 31)

 

111,800

 

110,000

 

112,400

 

117,400

 

116,800

 

−0.5

Personnel expenses (including pension expenses) (€ million)

 

8,726

 

9,194

 

9,430

 

9,693

 

11,203

 

+15.6

Proportion of women in senior management (%)

 

22

 

23

 

25

 

26

 

28

 

 

Number of nationalities in the Group Leadership Circle

 

22

 

23

 

31

 

35

 

33

 

−5.7

Proportion of employees with health insurance (%)

 

94

 

94

 

95

 

96

 

96

 

 

Proportion of employees covered by collective agreements on pay and conditions (%)

 

54

 

53

 

54

 

52

 

53

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Safety11

 

 

 

 

 

 

 

 

 

 

 

 

Recordable Incident Rate for Bayer employees (RIR)

 

0.56

 

0.49

 

0.47

 

0.43

 

0.42

 

−1.6

Lost Time Recordable Incident Rate for Bayer employees (LTRIR)

 

0.31

 

0.27

 

0.26

 

0.22

 

0.21

 

−6.4

Loss of Primary Containment Incident Rate (LoPC-IR)12

 

 

0.38

 

0.35

 

0.23

 

0.22

 

−7.7

 

 

 

 

 

 

 

 

 

 

 

 

 

Environmental Protection11

 

 

 

 

 

 

 

 

 

 

 

 

Primary energy consumption (petajoules13 / a)

 

50.10

 

49.05

 

47.58

 

45.57

 

43.00

 

−5.7

Secondary energy consumption (petajoules13 / a)

 

34.85

 

34.14

 

33.27

 

39.74

 

40.19

 

+1.1

Energy efficiency (MWh / t)14

 

3.63

 

3.50

 

3.44

 

3.37

 

3.34

 

−0.6

Direct greenhouse gas emissions (CO2 equivalents in million t)15

 

4.23

 

4.24

 

4.09

 

4.02

 

4.41

 

+9.7

Indirect greenhouse gas emissions (CO2 equivalents in million t), according to the market-based method15

 

 

4.72

 

4.91

 

5.53

 

5.30

 

−4.1

Specific greenhouse gas emissions (CO2 equivalents in t / manufactured sales volume in t), according to the market-based method15,16

 

 

1.06

 

1.09

 

1.12

 

1.19

 

+6.0

Volatile organic compounds (VOC) (thousand t / a)17

 

2.69

 

2.60

 

2.27

 

2.12

 

1.61

 

−24.0

Total organic carbon (TOC) (thousand t / a)

 

1.50

 

1.42

 

1.53

 

1.20

 

1.16

 

−3.3

Hazardous waste generated (thousand t / a)

 

474

 

603

 

467

 

487

 

541

 

+11.1

Water use (million m3 / a)

 

411

 

384

 

361

 

350

 

346

 

−1.1